Skip to Main Content

Paper Details

TrkA overexpression in non-tumorigenic human breast cell lines confers oncogenic and metastatic properties.
Breast Cancer Res Treat
10
2020
-IMEC, -NTRK1 fusion vector, CD74, MAPKinase, MCF10A, MCF10A cells, NTRK, NTRK fusions, NTRK1, NTRK1 fusions, NTRK1 vector, PI3Kinase, TNBC, Trk, Trk fusions, TrkA, TrkA overexpressing cells, breast cancer, breast cancer cells, breast cancers, cancers, hTERT, hTERT-IMEC, human, human cells, larotrectinib, non-tumorigenic breast cell, non-tumorigenic human breast cell lines, overexpressing, overexpressing cells, patients, triple-negative breast cancers, tumors
Author NameAffiliation
Konstantinos KonstantopoulosThe Johns Hopkins University
Ben Ho ParkThe Sidney Kimmel Comprehensive Cancer Center, The Johns Hopkins University School of Medicine
Ben Ho ParkThe Johns Hopkins University
Ben Ho ParkVanderbilt-Ingram Cancer Center, Vanderbilt University Medical Center
Ben Ho ParkVanderbilt University Medical Center, The Vanderbilt-Ingram Cancer Center
Ben Ho ParkThe Sidney Kimmel Comprehensive Cancer Center, The Johns Hopkins University School of Medicine
Ben Ho ParkThe Johns Hopkins University
Ben Ho ParkVanderbilt-Ingram Cancer Center, Vanderbilt University Medical Center
Ben Ho ParkVanderbilt University Medical Center, The Vanderbilt-Ingram Cancer Center
  • 1 - 9

Datasets

Release 1.2